A specialty pharmaceutical manufacturer focused on developing, producing, and marketing generic and branded medications, with particular strength in complex generics and central nervous system therapies. The company operated both a generic drug portfolio and a smaller branded segment targeting neuro...
This page tracks all publicly disclosed congressional trades in Impax Laboratories, Inc. (IPXL), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 1 purchase and 0 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-31 | Josh Gottheimer | buy | $1K – $15K |